Naloxone Take Home program prompts shortage

Next major import of drug not due until mid-November Just six weeks after the launch of the national Take Home Naloxone program there is already a significant shortage of the intranasal version of the opioid overdose resuscitation drug, with the TGA saying existing stocks are for “emergency supply only”. A recently published TGA shortage notice

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Changes for ‘better work-life balance’
Next Top 10 drugs in PDL incident reports